Section 3(d) of the Indian Patent Act, 1970 is one of the most important sections while prosecuting pharmaceutical patent applications in India.
About the Author: Prity Khastgir is a Biotech and Pharma Patent Attorney at Tech Corp Legal LLP, an Indian law firm based in New Delhi. She also serves as Director at Tech Corp International Consultants Pte. Ltd. (Singapore), wherein she advises clients regarding creation and monetization of intangible assets. Academically, Prity is a Goldman Sach 10,000 Women Entrepreneur Scholar certified by Indian School of Business (ISB, Hyderabad).